Last reviewed · How we verify

NCT04866251

Prevalence of Gag Reflex in Healthy Persons and Across Different Patient Groups and Its Relevance in Dysphagia Screening

Recruiting now NA Last updated 8 July 2024
What this trial tests

NA trial testing Gag reflex test; assessment of Mallampati Score in Neurological Diseases or Conditions in 700 participants. Currently enrolling.

Timeline
10 August 2016
Primary endpoint
1 July 2024
1 July 2024

Quick facts

Lead sponsorUniversity of Giessen
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment700
Start date10 August 2016
Primary completion1 July 2024
Estimated completion1 July 2024
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University of Giessen

Who can join

18 and older, any sex, with Neurological Diseases or Conditions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the prevalence of gag reflex in healthy young and healthy older subjects as well as in acute stroke patients, in patients with Parkinsons´s Disease, Myasthenia gravis, Multiple Sclerosis and in geriatric patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Neurological Diseases or Conditions

Currently open trials in the same condition.

Other University of Giessen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04866251.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing